Nouveau Life Pharmaceuticals, Inc.

Nouveau Life Pharmaceuticals, Inc.

OOTC:NOUV
0.00
USD
0.00
(0.00%)
-0.02EPS
5.12MMarket Cap
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.01
-0.01
-0.02
-0.01
-0.01
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.03
-0.03
-0.03
-0.03
0.01
- -
Tangible Book Value per Share
-0.03
-0.03
-0.03
-0.03
-0.01
-0.01
Basic Weighted Avg Shares
22
22
24
26
28
30
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Working Capital
-1
-1
-1
-1
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
Total Equity
-1
-1
-1
-1
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
-219.52

Capital Structure

USD

•

in mil. unless spec.
Sep'08
Dec'08
Mar'08
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
30
30
Market Capitalization
8
6
5

Working Capital

USD

•

in mil. unless spec.
Sep'08
Dec'08
Mar'08
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-136.36%
Free Cash Flow
- -
- -
-73.03%
Net Income, GAAP
- -
- -
39.11%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
-0.01
2007
- -
- -
- -
- -
-0.01
2008
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

CEO
Sang Tae Choi
Full Time Employees
- -
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
3580 Wilshire Blvd Los Angeles CA United States 90010
IPO Date
Jun 21, 2001
Website
nouv.ai
Business
Nouveau Life Pharmaceuticals, Inc. functions as a development stage enterprise, concentrating its efforts on innovative healthcare solutions. The company is actively engaged in the creation and deployment of non-face-to-face care services, including the SeniorGo.ai social communication platform designed for the global senior population. This platform offers diverse media, alongside information pertaining to medical services, insurance, pharmacy, finance, and entertainment. While exploring robotic and AI-driven healthcare devices, the company acknowledges the inherent uncertainties in these ventures regarding both success and profitability. Historically, the organization focused on developing nutraceutical products and natural wellness alternatives. The entity, originally incorporated in 1998 under the name Polo Equities, later operated as Hybrid Fuels, Inc., before adopting the Nouveau Life Pharmaceuticals, Inc. designation in May 2012. The company maintains its operational base in Los Angeles, California, and operates as a subsidiary of EMG Marketing Solutions, Inc.